{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:26:30Z","timestamp":1727497590048},"reference-count":171,"publisher":"IntechOpen","isbn-type":[{"type":"print","value":"9781803561851"},{"type":"electronic","value":"9781803561868"}],"license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Palliative care considered as a support care for anyone living with a complex disease such as cancer, it has a great role in decreasing the severity of illness and slowness loss of functions by symptoms control and management in different stages of cancer. Palliative care is a specialized care area bounded to deliver health care facilities to patients who suffer from direct, indirect symptoms, unmet needs, for prevention and relief suffering from psychological issues mainly emotional issues (depression, anxiety, and delirium) and physiological issues like (nausea, vomiting, fatigue, xerostomia, headache, osteoradionecrosis, hemoptysis, dyspnea, taste loss, and pain). So its goal is to prolong their survival with the best possible quality of life for both the patients and their families.<\/jats:p>","DOI":"10.5772\/intechopen.105220","type":"book-chapter","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:19:53Z","timestamp":1656069593000},"source":"Crossref","is-referenced-by-count":0,"title":["Palliative Care Therapies"],"prefix":"10.5772","author":[{"given":"Aisha","family":"Muthanna Shanshal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3774","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"ref=1","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today. Vol. 17. Lyon, France: International Agency for Research on Cancer; 2018. pp. 1-6"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Bausewein C, Booth S, Gysels M, et al. Understanding breathlessness: Cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. Journal of Palliative Medicine. 2010;13:1109-1118","DOI":"10.1089\/jpm.2010.0068"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Patrick D, Ferketich S, Frame P, et al. National Institutes of Health state of the science conference statement: Symptom management in cancer: Pain, depression and fatigue. Journal of the National Cancer Institute. Monographs. 2004;32:9-16","DOI":"10.1093\/jncimonographs\/djg014"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Jacobsen PB, Andrykowski MA. Tertiary prevention in cancer care: Understanding and addressing the psychological dimensions of cancer during the active treatment period. The American Psychologist. 2015;70(2):134","DOI":"10.1037\/a0036513"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: A systematic review. Journal of Pain and Symptom Management. 2007;34(1):94-104","DOI":"10.1016\/j.jpainsymman.2006.10.015"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Hessissen L, Kili A. Palliative care in Moroccan children with cancer: What are the parent\u2019s and children\u2019s needs? Palliative Medicine and Hospice Care \u2013 Open Journal. 2017;SE(1):S56-S583","DOI":"10.17140\/PMHCOJ-SE-1-112"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families? The Cancer Journal. 2010;16(5):423-435","DOI":"10.1097\/PPO.0b013e3181f684e5"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: How and when? The Oncologist. 2012;17(2):267-273","DOI":"10.1634\/theoncologist.2011-0219"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology. 2016;130(S2):S198-S207","DOI":"10.1017\/S0022215116000633"},{"key":"ref=10","unstructured":"World Health Organization. Definition of Palliative Care. 2008. Available from: http:\/\/www.who.int\/cancer\/palliative\/definition\/en\/ [Accessed: 27 July 2015]"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Ghafoor I, Hafeez H, Naz F, Baker MA. Comparison of documented patient care before and after implementation of end of life care pathway for terminally ill patients at Shaukat Khanum Memorial Cancer Hospital and Research Centre. Journal of Cancer & Allied Specialties. 2018;4(3)","DOI":"10.37029\/jcas.v4i3.196"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Yamaguchi T, Kuriya M, Morita T, Agar M, Choi YS, Goh C, et al. Palliative care development in the Asia-Pacific region: An International Survey from the Asia Pacific Hospice Palliative Care Network (APHN). BMJ Supportive & Palliative Care. 2017;7(1):23-31","DOI":"10.1136\/bmjspcare-2013-000588"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, et al. Referral criteria for outpatient specialty palliative cancer care: An international consensus. The Lancet Oncology. 2016;17(12):e552-e559","DOI":"10.1016\/S1470-2045(16)30577-0"},{"key":"ref=14","unstructured":"Rassouli M, Sajjadi M. Palliative care in the Islamic Republic of Iran. In: Silberman M, editor. Palliative Care to the Cancer Patient: The Middle East as a Model for Emerging Countries. New York: Nova; 2014"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Connor SR, Centeno C, Garralda E, Clelland D, Clark D. Estimating the number of patients receiving specialized palliative care globally in 2017. Journal of Pain and Symptom Management. 2021;61(4):812-816","DOI":"10.1016\/j.jpainsymman.2020.09.036"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Reis A, Pedrosa A, Dourado M, Reis C. Information and communication technologies in long-term and palliative care. Procedia Technology. 2013;9:1303-1312","DOI":"10.1016\/j.protcy.2013.12.146"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, LeGrand SB, et al. Symptom evaluation in palliative medicine: Patient report vs systematic assessment. Supportive Care in Cancer. 2006;14(5):444-453","DOI":"10.1007\/s00520-005-0009-2"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Currow DC, Allingham S, Yates P, Johnson C, Clark K, Eagar K. Improving national hospice\/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking. Supportive Care in Cancer. 2015;23(2):307-315","DOI":"10.1007\/s00520-014-2351-8"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Haun MW, Estel S, R\u00fccker G, Friederich HC, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database of Systematic Reviews. 2017;12(6):6","DOI":"10.1002\/14651858.CD011129.pub2"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Clark D. Total pain\u2019, disciplinary power and the body in the work of Cicely Saunders, 1958-1967. Social Science & Medicine. 1999;49(6):727-736","DOI":"10.1016\/S0277-9536(99)00098-2"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Al Saraireh FA, Aloush SM, Al Azzam M, Al Bashtawy M. The effectiveness of cognitive behavioral therapy versus psychoeducation in the management of depression among patients undergoing haemodialysis. Issues in Mental Health Nursing. 2018;39(6):514-518","DOI":"10.1080\/01612840.2017.1406022"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Karim SM, Zekri J, Abdelghany E, Dada R, Munsoor H, Ahmad I. Time from last chemotherapy to death and its correlation with the end of life care in a referral hospital. Indian Journal of Medical and Paediatric Oncology. 2015;36(1):55","DOI":"10.4103\/0971-5851.151792"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Pritchard S, Cuvelier G, Harlos M, Barr R. Palliative care in adolescents and young adults with cancer. Cancer. 2011;117(S10):2323-2328","DOI":"10.1002\/cncr.26044"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of early integratedpalliative care in patients with lung and GI cancer: A randomized clinical trial. Journal of Clinical Oncology. 2017;35(8):834","DOI":"10.1200\/JCO.2016.70.5046"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Ferrell BR, Temel JS, Temin S, Smith TJ. Integration of palliative care into standard oncology care: ASCO clinical practice guideline update summary. Journal of Oncology Practice\/ American Society of Clinical Oncology. 2017;13(2):119-121","DOI":"10.1200\/JOP.2016.017897"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Hui D et al. Concepts and definitions for \u201csupportive care,\u201d \u201cbest supportive care,\u201d \u201cpalliative care,\u201d and \u201chospice care\u201d in the published literature, dictionaries, and textbooks. Supportive Care in Cancer. 2013;21(3):659-685","DOI":"10.1007\/s00520-012-1564-y"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Smith TH, Cassel JB. Cost and non-clinical outcomes of palliative care. Journal of Pain and Symptom Management. 2009;38:32-44","DOI":"10.1016\/j.jpainsymman.2009.05.001"},{"key":"ref=28","unstructured":"Goodarzi E, Sohrabivafa M, Adineh HA, Moayed L, Khazaei Z. Geographical distribution global incidence and mortality of lung cancer and its relationship with the Human Development Index (HDI); an ecology study in 2018. World Cancer Research Journal. 2019;6:11"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 2016;11(1):39-51","DOI":"10.1016\/j.jtho.2015.09.009"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: A systematic review and meta-analysis. Systematic Reviews. 2013;2:10","DOI":"10.1186\/2046-4053-2-10"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: A real-world crosssectional study. Supportive Care in Cancer. 2014;22(1):181-187","DOI":"10.1007\/s00520-013-1959-4"},{"key":"ref=32","unstructured":"NCCN Guidelines\u00ae for Palliative Care Version 1. 2018. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf [Accessed: April 2018]"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Shih A, Jackson KC 2nd. Role of corticosteroids in palliative care. Journal of Pain & Palliative Care Pharmacotherapy. 2007;21(4):69-76","DOI":"10.1080\/J354v21n04_14"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Lossignol D. A little help from steroids in oncology. Journal of Translational Internal Medicine. 2016;4(1):52-54","DOI":"10.1515\/jtim-2016-0011"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Masuda E, Sista AK, Pua BB, Madoff DC. Palliative procedures in lung cancer. Seminars in Interventional Radiology. 2013;30(2):199-205","DOI":"10.1055\/s-0033-1342962"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Farbicka P, Nowicki A. Palliative care in patients with lung cancer. Contemporary Oncology. 2013;17(3):238-245","DOI":"10.5114\/wo.2013.35033"},{"key":"ref=37","unstructured":"Jassem E, Batura-Gabryel H, Cofta S, et al. Reccomendation of Polish Respiratory Society for palliative care in chronic lung diseases. Pulmonology and Allergology. 2012;80:41-64"},{"key":"ref=38","unstructured":"Jassem E, Jassem J. Duszno\u015b\u0107 w przebiegu raka p\u0142uca. Polish Medical. 2002;1:3-10"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Kloke M, Cherny N. Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology. 2015;26:v169-v173","DOI":"10.1093\/annonc\/mdv306"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy tomorphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management. 2006;31(1):38-47","DOI":"10.1016\/j.jpainsymman.2005.06.009"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Wildiers H, Dhaenekint C, Demeulenaere P, Clement PM, Desmet M, Van Nuffelen R, et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. Journal of Pain and Symptom Management. 2009;38(1):124-133","DOI":"10.1016\/j.jpainsymman.2008.07.007"},{"key":"ref=42","doi-asserted-by":"crossref","unstructured":"Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliative Medicine. 2001;15(4):329-336","DOI":"10.1191\/026921601678320313"},{"key":"ref=43","unstructured":"Leppert W. Leczenie objaw\u00f3w ze strony uk\u0142adu oddechowego u chorych na nowotwory. Nowiny Lekarskie. 2011;80:32-46"},{"key":"ref=44","doi-asserted-by":"crossref","unstructured":"Ferrel B, Levy MH, Paice J. Managing pain from advanced cancer in the palliative care setting. Clinical Journal of Oncology Nursing. 2008;12:575-581","DOI":"10.1188\/08.CJON.575-581"},{"key":"ref=45","doi-asserted-by":"crossref","unstructured":"Molassiotis A, Smith JA, Bennett MI, Blackhall F, Taylor D, Zavery B, et al. Clinical expert guidelines for the management of cough in lung cancer: Report of a UK task group on cough. Cough. 2010;6:9","DOI":"10.1186\/1745-9974-6-9"},{"key":"ref=46","doi-asserted-by":"crossref","unstructured":"Warren P, Burke C. Endovascular management of chronic upper extremity deep vein thrombosis and superior vena cava syndrome. Seminars in Interventional Radiology. 2011;28:32-38","DOI":"10.1055\/s-0031-1273938"},{"key":"ref=47","doi-asserted-by":"crossref","unstructured":"Mucke M, Mochamat, Cuhls H, Peuckmann-Post V, Minton O, Stone P, et al. Pharmacological treatments for fatigue associated with palliative care: Executive summary of a cochrane collaboration systematic review. Journal of Cachexia, Sarcopenia and Muscle. 2016;7(1):23-27","DOI":"10.1002\/jcsm.12101"},{"key":"ref=48","doi-asserted-by":"crossref","unstructured":"Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database of Systematic Reviews. 2012;11:11","DOI":"10.1002\/14651858.CD006145.pub3"},{"key":"ref=49","doi-asserted-by":"crossref","unstructured":"Dionne-Odom JN, Hull JG, Martin MY, Lyons KD, Prescott AT, Tosteson T, et al. Associations between advanced cancer patients\u2019 survival and family caregiver presence and burden. Cancer Medicine. 2016;5(5):853-862","DOI":"10.1002\/cam4.653"},{"key":"ref=50","unstructured":"Martin VR. Ovarian cancer. In: Henke YC, Wujcik D, Gobel BH, editors. Cancer Nursing Principles and Practice. 7th ed. 2011. pp. 1546-1579"},{"key":"ref=51","doi-asserted-by":"crossref","unstructured":"Mirza MR, Coleman RL, Gonz\u00e1lez-Mart\u00edn A, Moore KN, Colombo N, Ray-Coquard I, et al. The forefront of ovarian cancer therapy: Update on PARP inhibitors. Annals of Oncology. 2020;31(9):1148-1159","DOI":"10.1016\/j.annonc.2020.06.004"},{"key":"ref=52","doi-asserted-by":"crossref","unstructured":"Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M, et al. PARP inhibitors in the management of ovarian cancer: ASCO guideline. Obstetrical & Gynecological Survey. 2020;75(12):739-741","DOI":"10.1097\/OGX.0000000000000869"},{"key":"ref=53","doi-asserted-by":"crossref","unstructured":"Mendiola C, Valdiviezo N, Vega E, Sanchez Munoz A, Ciruelos EM, Manso L, et al. Altretamine for recurrent ovarian cancer or as maintenance after response to second-line therapy. Journal of Clinical Oncology. 2011;29(15_suppl):e15589","DOI":"10.1200\/jco.2011.29.15_suppl.e15589"},{"key":"ref=54","doi-asserted-by":"crossref","unstructured":"Talwar V, Goel V, Raina S, Patnaik N, Doval DC. Altretamine in advanced pretreated epithelial ovarian carcinoma patients: Experience from a center in North India. Current Medicine Research and Practice. 2016;6(3):109-112","DOI":"10.1016\/j.cmrp.2016.04.003"},{"key":"ref=55","unstructured":"Cannistra SA, Gershenson DM, Recht A. Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma. Cancer: Principles and Practise of Oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 1368-1391"},{"key":"ref=56","doi-asserted-by":"crossref","unstructured":"Morgan M, Boyd J, Drapkin R, Seiden MV. Ch 89\u2014Cancers arising in the ovary. In: Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier; 2014. p. 1592","DOI":"10.1016\/B978-1-4557-2865-7.00089-8"},{"key":"ref=57","unstructured":"Target Ovarian Cancer. Controlling Your Symptoms. 2017. Available from: https:\/\/targetovariancancer.org.uk\/information-and-support\/my-ovarian-cancer-incurable\/controlling-your-symptoms"},{"key":"ref=58","unstructured":"Mayo Clinic Staff. Ovarian Cancer. 2018. Available from: https:\/\/mayoclinic.org\/diseases-conditions\/ovarian-cancer\/basics\/definition\/con-20028096"},{"key":"ref=59","doi-asserted-by":"crossref","unstructured":"Peng X, et al. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer. 2015;13(1):1-6","DOI":"10.1186\/s12957-015-0455-3"},{"key":"ref=60","unstructured":"Treating Ovarian Cancer. n.d. Available from: https:\/\/cancer.org\/cancer\/ovariancancer\/detailedguide\/ovarian-cancer-treating-general-info"},{"key":"ref=61","unstructured":"What is Ovarian Cancer? 2018. Available from: https:\/\/cancer.org\/cancer\/ovariancancer\/detailedguide\/ovarian-cancer-what-is-ovarian-cancer"},{"key":"ref=62","doi-asserted-by":"crossref","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: Analysis of oncology electronic medical records in the United States. BMC Cancer. 2018;18(1):1-1","DOI":"10.1186\/s12885-017-3922-0"},{"key":"ref=63","doi-asserted-by":"crossref","unstructured":"Heindel W, G\u00fcbitz R, Vieth V, Weckesser M, Schober O, Sch\u00e4fers M. The diagnostic imaging of bone metastases. Deutsches \u00c4rzteblatt International. 2014;111(44):741","DOI":"10.3238\/arztebl.2014.0741"},{"key":"ref=64","doi-asserted-by":"crossref","unstructured":"Handkiewicz-Junak D, Poeppel TD, Bodei L, Aktolun C, Ezziddin S, Giammarile F, et al. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides. European Journal of Nuclear Medicine and Molecular Imaging. 2018;45:846-859","DOI":"10.1007\/s00259-018-3947-x"},{"key":"ref=65","doi-asserted-by":"crossref","unstructured":"Michael H-H, Tsai Y-Y, Ho_e, S.E. Overview of diagnosis and management of metastatic disease to bone. Cancer Control. 2012;19:84-91","DOI":"10.1177\/107327481201900202"},{"key":"ref=66","doi-asserted-by":"crossref","unstructured":"Mercadante S. Malignant bone pain: Pathophysiology and treatment. Pain. 1997;69:1-18","DOI":"10.1016\/S0304-3959(96)03267-8"},{"key":"ref=67","doi-asserted-by":"crossref","unstructured":"Roodman GD. Mechanisms of bone metastasis. The New England Journal of Medicine. 2004;350(16):1655-1664","DOI":"10.1056\/NEJMra030831"},{"key":"ref=68","doi-asserted-by":"crossref","unstructured":"Yoneda T, Hiasa M, Nagata Y, Okui T, White FA. Acidic microenvironment and bone pain in cancer-colonized bone. BoneKEy Reports. 2015;4. p. 690","DOI":"10.1038\/bonekey.2015.58"},{"key":"ref=69","doi-asserted-by":"crossref","unstructured":"Mantyh P. Bone cancer pain: Causes, consequences, and therapeutic opportunities. Pain. 2013;154:54-62","DOI":"10.1016\/j.pain.2013.07.044"},{"key":"ref=70","doi-asserted-by":"crossref","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W, Wordliczek J. Bone pain in cancer patients: Mechanisms and current treatment. International Journal of Molecular Sciences. 2019;20(23):6047","DOI":"10.3390\/ijms20236047"},{"key":"ref=71","doi-asserted-by":"crossref","unstructured":"Iqbal MS, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D, et al. Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. Radiotherapy and Oncology. 2018;126(3):558-567","DOI":"10.1016\/j.radonc.2017.12.011"},{"key":"ref=72","doi-asserted-by":"crossref","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence. Nature Reviews. Cancer. 2015;15(7):409-425","DOI":"10.1038\/nrc3958"},{"key":"ref=73","doi-asserted-by":"crossref","unstructured":"Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. The New England Journal of Medicine. 2008;359(11):1116-1127","DOI":"10.1056\/NEJMoa0802656"},{"key":"ref=74","doi-asserted-by":"crossref","unstructured":"Vermorken JB, Remenar E, Van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England Journal of Medicine. 2007;357(17):1695-1704","DOI":"10.1056\/NEJMoa071028"},{"key":"ref=75","doi-asserted-by":"crossref","unstructured":"Saito AM, Landrum MB, Neville BA, Ayanian JZ, Earle CC. The effect on survival of continuing chemotherapy to near death. BMC Palliative Care. 2011;10(1):1-1","DOI":"10.1186\/1472-684X-10-14"},{"key":"ref=76","doi-asserted-by":"crossref","unstructured":"Caponigro F, Massa E, Manzione L, Rosati G, Biglietto M, De Lucia L, et al. Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Annals of Oncology. 2001;12(2):199-202","DOI":"10.1023\/A:1008322415335"},{"key":"ref=77","doi-asserted-by":"crossref","unstructured":"Manafi-Farid R, Masoumi F, Divband G, Saidi B, Ataeinia B, Hertel F, et al. Targeted palliative radionuclide therapy for metastatic bone pain. Journal of Clinical Medicine. 2020;9(8):2622","DOI":"10.3390\/jcm9082622"},{"key":"ref=78","doi-asserted-by":"crossref","unstructured":"Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252-1261","DOI":"10.1053\/j.gastro.2013.01.068"},{"key":"ref=79","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424","DOI":"10.3322\/caac.21492"},{"key":"ref=80","doi-asserted-by":"crossref","unstructured":"Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: An update. Digestive Diseases. 2010;28(4-5):645-656","DOI":"10.1159\/000320068"},{"key":"ref=81","doi-asserted-by":"crossref","unstructured":"Kanno A, Masamune A, Hanada K, Kikuyama M, Kitano M. Advances in early detection of pancreatic cancer. Diagnostics. 2019;9(1). p. 18","DOI":"10.3390\/diagnostics9010018"},{"key":"ref=82","doi-asserted-by":"crossref","unstructured":"Bet\u00e9s M, Gonz\u00e1lez V\u00e1zquez S, Boj\u00f3rquez A, Lozano MD, Echeveste JI, Garc\u00eda Albarr\u00e1n L, et al. Metastatic tumors in the pancreas: The role of endoscopic ultrasound-guided fine-needle aspiration. Revista Espa\u00f1ola de Enfermedades Digestivas. 2019;111(5):345-350","DOI":"10.17235\/reed.2019.5914\/2018"},{"key":"ref=83","doi-asserted-by":"crossref","unstructured":"De Luca L, Repici A, Ko\u00e7ollari A, Auriemma F, Bianchetti M, Mangiavillano B. Pancreatoscopy: An update. World Journal of Gastrointestinal Endoscopy. 2019;11(1):22-30","DOI":"10.4253\/wjge.v11.i1.22"},{"key":"ref=84","doi-asserted-by":"crossref","unstructured":"Winter JM, Brennan MF, Tang LH, et al. Survival after resection of pancreatic adenocarcinoma: Results from a single institution over three decades. Annals of Surgical Oncology. 2012;19(1):169-175","DOI":"10.1245\/s10434-011-1900-3"},{"key":"ref=85","doi-asserted-by":"crossref","unstructured":"Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarcinoma: Is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a \u201ctrue\u201d R0 resection? Annals of Surgery. 2013;257(4):731-736","DOI":"10.1097\/SLA.0b013e318263da2f"},{"key":"ref=86","doi-asserted-by":"crossref","unstructured":"Stathis A, Moore MJ. Advanced pancreatic carcinoma: Current treatment and future challenges. Nature Reviews. Clinical Oncology. 2010;7(3):163-172","DOI":"10.1038\/nrclinonc.2009.236"},{"key":"ref=87","doi-asserted-by":"crossref","unstructured":"Dimou F, Sineshaw H, Parmar AD, Tamirisa NP, Jemal A, Riall TS. Trends in receipt and timing of multimodality therapy in early-stage pancreatic cancer. Journal of Gastrointestinal Surgery. 2016;20(1):93-103","DOI":"10.1007\/s11605-015-2952-7"},{"key":"ref=88","doi-asserted-by":"crossref","unstructured":"Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology. 2008;26(21):3496-3502","DOI":"10.1200\/JCO.2007.15.8634"},{"key":"ref=89","doi-asserted-by":"crossref","unstructured":"Varadhachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology. 2008;26(21):3487-3495","DOI":"10.1200\/JCO.2007.15.8642"},{"key":"ref=90","doi-asserted-by":"crossref","unstructured":"Christians KK, Heimler JW, George B, et al. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery. 2016;159(3):893-900","DOI":"10.1016\/j.surg.2015.09.018"},{"key":"ref=91","doi-asserted-by":"crossref","unstructured":"Stark A, Hines OJ. Endoscopic and operative palliation strategies for pancreatic ductal adenocarcinoma. Seminars in Oncology. 2015;42(1):163-176","DOI":"10.1053\/j.seminoncol.2014.12.014"},{"key":"ref=92","doi-asserted-by":"crossref","unstructured":"House MG, Choti MA. Palliative therapy for pancreatic\/biliary cancer. The Surgical Clinics of North America. 2005;85(2):359-371","DOI":"10.1016\/j.suc.2005.01.022"},{"key":"ref=93","doi-asserted-by":"crossref","unstructured":"Maire F, Sauvanet A. Palliation of biliary and duodenal obstruction in patients with unresectable pancreatic cancer: Endoscopy or surgery? Journal of Visceral Surgery. 2013;150(3):S27-S31","DOI":"10.1016\/j.jviscsurg.2013.03.005"},{"key":"ref=94","doi-asserted-by":"crossref","unstructured":"Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Annals of Surgery. 1999;230(3):322-328","DOI":"10.1097\/00000658-199909000-00005"},{"key":"ref=95","doi-asserted-by":"crossref","unstructured":"Van Heek NT, DeCastro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: A prospective randomized multicenter trial with special focus on assessment of quality of life. Annals of Surgery. 2003;238(6):894-902","DOI":"10.1097\/01.sla.0000098617.21801.95"},{"key":"ref=96","doi-asserted-by":"crossref","unstructured":"Gurusamy KS, Kumar S, Davidson BR. Prophylactic gastrojejunostomy for unresectable periampullary carcinoma. Cochrane Database of Systematic Reviews. 2013;2","DOI":"10.1002\/14651858.CD008533.pub3"},{"key":"ref=97","doi-asserted-by":"crossref","unstructured":"Dallos MC, Eisenberger AB, Bates SE. Prevention of venous thromboembolism in pancreatic cancer: Breaking down a complex clinical dilemma. The Oncologist. 2020;25(2):132-139","DOI":"10.1634\/theoncologist.2019-0264"},{"key":"ref=98","doi-asserted-by":"crossref","unstructured":"Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: Prevalence, severity and impact on quality of life. Supportive Care in Cancer. 2010;18(8):1039-1060","DOI":"10.1007\/s00520-010-0827-8"},{"key":"ref=99","doi-asserted-by":"crossref","unstructured":"Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Diseases. 2002;8(3):117-129","DOI":"10.1034\/j.1601-0825.2002.02851.x"},{"key":"ref=100","unstructured":"Toth BB, Chambers MS, Fleming TJ, Lemon JC, Martin JW. Minimizing oral complications of cancer treatment. Oncology (Williston Park, N.Y.). 1995;9(9):851"},{"key":"ref=101","unstructured":"Toth BB, Chambers MS, Fleming TC. Prevention and management of oral complications associated with cancer therapies: Radiotherapy\/chemotherapy. Texas Dental Journal. 1996;113(6):23-29"},{"key":"ref=102","doi-asserted-by":"crossref","unstructured":"Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer. Supportive Care in Cancer. 2000;8(5):372-376","DOI":"10.1007\/s005200050005"},{"key":"ref=103","doi-asserted-by":"crossref","unstructured":"Sweeney MP, Bagg J, Baxter WP, Aitchison TC. Oral disease in terminally ill cancer patients with xerostomia. Oral Oncology. 1998;34(2):123-126","DOI":"10.1016\/S1368-8375(97)00076-6"},{"key":"ref=104","doi-asserted-by":"crossref","unstructured":"\u00d6hrn KE, Wahlin YB, Sj\u00f6d\u00e9n PO. Oral status during radiotherapy and chemotherapy: A descriptive study of patient experiences and the occurrence of oral complications. Supportive Care in Cancer. 2001;9(4):247-257","DOI":"10.1007\/s005200000214"},{"key":"ref=105","doi-asserted-by":"crossref","unstructured":"Hammerlid E, Mercke C, Sullivan M, Westin T. A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncology. 1997;33(3):189-196","DOI":"10.1016\/S0964-1955(96)00069-3"},{"key":"ref=106","unstructured":"Takahashi Y. Influences of oral health-related quality of life of cancer patients in the terminal phase. Journal of the Japanese Society for Disability and Oral Health. 2011;5:23-37"},{"key":"ref=107","unstructured":"Davies A, Finlay I. Oral care in advanced disease. Oral Care in Advanced Disease. 2011:1-250"},{"key":"ref=108","doi-asserted-by":"crossref","unstructured":"Sweeney MP, Bagg J. The mouth and palliative care. The American Journal of Hospice & Palliative Care. 2000;17(2):118-124","DOI":"10.1177\/104990910001700212"},{"key":"ref=109","unstructured":"Treister NS, Villa DA, Thompson L. Palliative care: Overview of mouth care at the end of life. Depression. 2020;3:7"},{"key":"ref=110","doi-asserted-by":"crossref","unstructured":"Wu TY, Liu HY, Wu CY, Chen HC, Huang ST, Chen PH. Professional oral care in end-of-life patients with advanced cancers in a hospice ward: Improvement of oral conditions. BMC Palliative Care. 2020;19(1):1-5","DOI":"10.1186\/s12904-020-00684-0"},{"key":"ref=111","doi-asserted-by":"crossref","unstructured":"Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clinical Advances in Hematology & Oncology. 2008;6(10):742-750","DOI":"10.1007\/s11912-008-0027-6"},{"key":"ref=112","doi-asserted-by":"crossref","unstructured":"Floriano TF, Heguedusch D, Pareja GN, Oliveira SV, Domaneschi C, de Barros Gallo C. Dental management in palliative care of a patient with advanced oral cancer: A case report. Journal of Oral Diagnosis. 2021;6(1):1-6","DOI":"10.5935\/2525-5711.20210003"},{"key":"ref=113","doi-asserted-by":"crossref","unstructured":"McDermott JD, Eguchi M, Stokes WA, Amini A, Hararah M, Ding D, et al. Short-and long-term opioid use in patients with oral and oropharynx cancer. Otolaryngology \u2013 Head and Neck Surgery. 2019;160(3):409-419","DOI":"10.1177\/0194599818808513"},{"key":"ref=114","doi-asserted-by":"crossref","unstructured":"Sekido K, Tomihara K, Horikawa H, Tachinami H, Murakami N, Noguchi M. Successful control of opioid-refractory cancer pain with methadone in a patient with advanced oral squamous cell carcinoma: A case report. Oral Science International. 2018;15(2):78-80","DOI":"10.1016\/S1348-8643(18)30004-1"},{"key":"ref=115","unstructured":"Elad S, Horowitz R, Zadik Y. Supportive and Palliative Care in Dentistry and Oral Medicine. The Art and Science of Palliative Medicine. Hong Kong: AME Publishing Company; 2014. pp. 385-405"},{"key":"ref=116","doi-asserted-by":"crossref","unstructured":"Arjan V et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Snccesses and barriers. International Journal of Radiation Oncology, Biology, Physics. 2010;78(4):983-991","DOI":"10.1016\/j.ijrobp.2010.06.052"},{"key":"ref=117","doi-asserted-by":"crossref","unstructured":"Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, et al. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncology. 2007;43:137-142","DOI":"10.1016\/j.oraloncology.2006.01.013"},{"key":"ref=118","doi-asserted-by":"crossref","unstructured":"Jaguar GC, Lima EN, Kowalski LP, Pellizzon AC, Carvalho AL, et al. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients. Radiotherapy and Oncology. 2015;115:253-256","DOI":"10.1016\/j.radonc.2015.03.017"},{"key":"ref=119","doi-asserted-by":"crossref","unstructured":"Park B, Noh H, Choi DJ. Herbal medicine for xerostomia in cancer patients: A systematic review of randomized controlled trials. Integrative Cancer Therapies. 2018;17(2):179-191","DOI":"10.1177\/1534735417728336"},{"key":"ref=120","doi-asserted-by":"crossref","unstructured":"Ni X, Yu Y, Tian T, Liu L, Li X, Li F, et al. Acupuncture for patients with cancer-induced xerostomia: A systematic review protocol. BMJ Open. 2019;9(12):e031892","DOI":"10.1136\/bmjopen-2019-031892"},{"key":"ref=121","unstructured":"Berk LB, Shivnani AT, Small W Jr. Pathophysiology and management of radiation-induced xerostomia. The Journal of Supportive Oncology. 2005;3:191-200"},{"key":"ref=122","doi-asserted-by":"crossref","unstructured":"Coppes RP, Zeilstra LJW, Kapinga HH, Konings AWT. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. British Journal of Cancer. 2001;85:1055-1063","DOI":"10.1054\/bjoc.2001.2038"},{"key":"ref=123","doi-asserted-by":"crossref","unstructured":"Ravasco P. Aspects of taste and compliance in patients with cancer. European Journal of Oncology Nursing. 2005;9:S84-S91","DOI":"10.1016\/j.ejon.2005.09.003"},{"key":"ref=124","doi-asserted-by":"crossref","unstructured":"Afraseyabi S, Afkhamzadeh A, Sabori H, Verdi F, Khaksar N, Mosavei B. Oral candidiasis amongst cancer patients at Qods Hospitals in Sanandaj. African Journal of Clinical and Experimental Microbiology. 2011;12(3):1595-1689","DOI":"10.4314\/ajcem.v12i3.8"},{"key":"ref=125","doi-asserted-by":"crossref","unstructured":"Lalla RV, Latortue MC, Hong CH, et al. A systematic review of oral fungal infections in patients receiving cancer therapy. Supportive Care in Cancer. 2010;18(8):985-992","DOI":"10.1007\/s00520-010-0892-z"},{"key":"ref=126","doi-asserted-by":"crossref","unstructured":"Brondel L, Jacquin A, Meillon S, P\u00e9nicaud L. Le go\u00fbt: Physiologie, r\u00f4les et dysfonctionnements. Nutrition Clinique et M\u00e9tabolisme. 2013;27(3):123-133","DOI":"10.1016\/j.nupar.2013.06.002"},{"key":"ref=127","unstructured":"Malaty J, Malaty IA. Smell and taste disorders in primary care. American Family Physician. 2013;88(12):852-859"},{"key":"ref=128","doi-asserted-by":"crossref","unstructured":"Halyard MY, Jatoi A, Sloan JA, Bearden JD III, Vora SA, Atherton PJ, et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). International Journal of Radiation Oncology, Biology, Physics. 2007;67(5):1318-1322","DOI":"10.1016\/j.ijrobp.2006.10.046"},{"key":"ref=129","unstructured":"Mizukami Y, Sato J, Nihei S, Kashiwaba M, Kudo K, Okuyama H, et al. The effectiveness of polaprezinc preparation for taste alteration in cancer chemotherapy. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 2016;43(8):979-983"},{"key":"ref=130","doi-asserted-by":"crossref","unstructured":"Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: The first selective-target and broad-spectrum radioprotector. The Oncologist. 2007;12(6):738-747","DOI":"10.1634\/theoncologist.12-6-738"},{"key":"ref=131","unstructured":"Shokohi T, Bandalizadeh Z, Hedayati MT, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur Journal of Microbiology. 2011;4(1):S19-S26"},{"key":"ref=132","unstructured":"Wl W. Scarborough je osteoradionecrosis in intra-oral cancer. American Journal of Roentgenology. 1938;40:524-534"},{"key":"ref=133","doi-asserted-by":"crossref","unstructured":"Silvestre-Rangil J, Silvest F-J. Clinico-theraper-rtic management of osteoradionecrosis: A literature review and update. Medicina Oral, Patolog\u00eda Oral y Cirug\u00eda Bucal. 2011;16(7):E900-E904","DOI":"10.4317\/medoral.17257"},{"key":"ref=134","doi-asserted-by":"crossref","unstructured":"Re M. A new concept in treatment of osteoradionecrosis. Journal of Oral and Maxillofacial Surgery. 1983;41:351-357","DOI":"10.1016\/S0278-2391(83)80005-6"},{"key":"ref=135","doi-asserted-by":"crossref","unstructured":"Adam SJ et al. Paradigm shifts ln the management of osteoradionecrosis of mandible. Oral Oncology. 2010;46:95-801","DOI":"10.1016\/j.oraloncology.2010.08.007"},{"key":"ref=136","doi-asserted-by":"crossref","unstructured":"Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, et al. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology. 2016;27:v119-v133","DOI":"10.1093\/annonc\/mdw270"},{"key":"ref=137","doi-asserted-by":"crossref","unstructured":"Louie KS, Mehanna H, Sasieni P. Trends in head and neck cancers in England from 1995-2011 and projections up to 2025. Oral Oncology. 2015;51(4):341-348","DOI":"10.1016\/j.oraloncology.2015.01.002"},{"key":"ref=138","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics 2017. CA: A Cancer Journal for Clinicians. 2017;67(1):7-30","DOI":"10.3322\/caac.21387"},{"key":"ref=139","doi-asserted-by":"crossref","unstructured":"De La Cruz M, Fan J, Yennu S, Tanco K, Shin S, Wu J, et al. The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Supportive Care in Cancer. 2015;23:2427-2433","DOI":"10.1007\/s00520-015-2610-3"},{"key":"ref=140","doi-asserted-by":"crossref","unstructured":"Hui D. Delirium in the palliative care setting: \u201cSorting\u201d out the confusion. Palliative Medicine. 2019;33:863-864","DOI":"10.1177\/0269216319861896"},{"key":"ref=141","doi-asserted-by":"crossref","unstructured":"Rudolph JL, Archambault E, Kelly B, Force VABDT. A delirium risk modification program is associated with hospitaloutcomes. Journal of the American Medical Directors Association. 2014;15(957):e7-e11","DOI":"10.1016\/j.jamda.2014.08.009"},{"key":"ref=142","doi-asserted-by":"crossref","unstructured":"Schoen MW, Cull S, Buckhold FR. False bed alarms: A teachable moment. JAMA Internal Medicine. 2016;176:741-742","DOI":"10.1001\/jamainternmed.2016.1885"},{"key":"ref=143","doi-asserted-by":"crossref","unstructured":"Grassi L, Caraceni A, Mitchell A, Nanni MG, Berardi MA, Caruso R, et al. Management of delirium in palliativecare: A review. Current Psychiatry Reports. 2015;17:1-9","DOI":"10.1007\/s11920-015-0550-8"},{"key":"ref=144","doi-asserted-by":"crossref","unstructured":"Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: A randomized clinical trial. JAMA Internal Medicine. 2017;177:34-42","DOI":"10.1001\/jamainternmed.2016.7491"},{"key":"ref=145","doi-asserted-by":"crossref","unstructured":"Mattiuzzi C, Sanchis-Gomar F, Lippi G. Concise update on colorectal cancer epidemiology. Annals of Translational Medicine. 2019;7(21):609-613","DOI":"10.21037\/atm.2019.07.91"},{"key":"ref=146","doi-asserted-by":"crossref","unstructured":"Rudler M et al. Optimal management of ascites. Liver International. 2020;40:128-135","DOI":"10.1111\/liv.14361"},{"key":"ref=147","doi-asserted-by":"crossref","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians. 2015;65(2):87-108","DOI":"10.3322\/caac.21262"},{"key":"ref=148","unstructured":"National Institutes of Health National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Cancer Stat Facts: Bladder Cancer. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html [Accessed: 11 August 2017]"},{"key":"ref=149","unstructured":"Didkowska J, Wojciechowska U, Zato\u0144ski W. Nowotwory z\u0142o\u015bliwe w Polsce w 2011 roku. Warszawa: Krajowy Rejestr Nowotwor\u00f3w; 2013"},{"key":"ref=150","unstructured":"Oya H, Koike M, Iwata N, Kobayashi D, Matoba M. Pain management for urological cancer patients in palliative care. Journal of Palliative Care and Medicine. 2013;3(168):2"},{"key":"ref=151","unstructured":"National Collaborating Centre for Cancer (UK). Bladder Cancer: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2015"},{"key":"ref=152","doi-asserted-by":"crossref","unstructured":"Suzuki K, Hanashima F, Shirotake S, Kodaira K, Nishimoto K, Takahashi T, et al. Determining the optimum way to maintain quality of life for very elderly patients with advanced bladder cancer and poor performance status: A case report. Molecular and Clinical Oncology. 2017;6(6):968-970","DOI":"10.3892\/mco.2017.1236"},{"key":"ref=153","doi-asserted-by":"crossref","unstructured":"Daniels CJ, Wakefield PJ, Bub GA. Bladder metastasis presenting as neck, arm and thorax pain: A case report. Chiropractic & Manual Therapies. 2016;24:14","DOI":"10.1186\/s12998-016-0097-8"},{"key":"ref=154","doi-asserted-by":"crossref","unstructured":"Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention. 2017;26(6):809-815","DOI":"10.1158\/1055-9965.EPI-16-0889"},{"key":"ref=155","doi-asserted-by":"crossref","unstructured":"Thrift-Perry M, Cabanes A, Cardoso F, Hunt KM, Cruz TA, Faircloth K. Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey. Breast. 2018;41:93-106","DOI":"10.1016\/j.breast.2018.06.005"},{"key":"ref=156","doi-asserted-by":"crossref","unstructured":"Dange VN, Shid SJ, Magdum CS, Mohite SK. A review on breast cancer: An overview. Asian Journal of Pharmaceutical Research. 2017;7(1):49-51","DOI":"10.5958\/2231-5691.2017.00008.9"},{"key":"ref=157","doi-asserted-by":"crossref","unstructured":"Hariramani N, Jayanthi S. A systematic review of intrinsic factors and its influence in breast cancer. Research Journal of Pharmacy and Technology. 2018;11(8):3543-3546","DOI":"10.5958\/0974-360X.2018.00654.6"},{"key":"ref=158","doi-asserted-by":"crossref","unstructured":"Jayashree V, Velraj M. Breast cancer and various prognostic biomarkers for the diagnosis of the disease: A review. Research Journal of Pharmacy and Technology. 2017;10(9):3211-3216","DOI":"10.5958\/0974-360X.2017.00570.4"},{"key":"ref=159","doi-asserted-by":"crossref","unstructured":"Yadav AR, Mohite SK. Cancer\u2014A silent killer: An overview. Asian Journal of Pharmaceutical Research. 2020;10(3):213-216","DOI":"10.5958\/2231-5691.2020.00036.2"},{"key":"ref=160","doi-asserted-by":"crossref","unstructured":"Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. The New England Journal of Medicine. 1994;330:592-596","DOI":"10.1056\/NEJM199403033300902"},{"key":"ref=161","doi-asserted-by":"crossref","unstructured":"Li BT, Wong MH, Pavlakis N. Treatment and prevention of bone metastases from breast cancer: A comprehensive review of evidence for clinical practice. Journal of Clinical Medicine. 2014;3(1):1-24","DOI":"10.3390\/jcm3010001"},{"key":"ref=162","doi-asserted-by":"crossref","unstructured":"Mercadante S, Fulfaro F. Management of painful bone metastases. Current Opinion in Oncology. 2007;19(4):308-314","DOI":"10.1097\/CCO.0b013e3281214400"},{"key":"ref=163","doi-asserted-by":"crossref","unstructured":"Ripamonti CL, Santini D, Maranzano E, Berti M, Roila F. ESMO Guidelines Working Group. Management of cancer pain: ESMO clinical practice guidelines. Annals of Oncology. 2012;23:vii139-vii154","DOI":"10.1093\/annonc\/mds233"},{"key":"ref=164","doi-asserted-by":"crossref","unstructured":"Cherny NI, Paluch-Shimon S, Berner-Wygoda Y. Palliative care: Needs of advanced breast cancer patients. Breast Cancer: Targets and Therapy. 2018;10:231","DOI":"10.2147\/BCTT.S160462"},{"key":"ref=165","doi-asserted-by":"crossref","unstructured":"Juvet LK, Thune I, Elvsaas IK\u00d8, et al. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6-month follow-up: A meta-analysis. Breast. 2017;33:166-177","DOI":"10.1016\/j.breast.2017.04.003"},{"key":"ref=166","unstructured":"Mohandas H, Jaganathan SK, Mani MP, Ayyar M, Rohini Thevi GV. Cancer-related fatigue treatment: An overview. Journal of Cancer Research and Therapeutics. 2017;13(6):916-929"},{"key":"ref=167","doi-asserted-by":"crossref","unstructured":"Brunault P, Champagne AL, Huguet G. Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology. 2016;25:513-520","DOI":"10.1002\/pon.3947"},{"key":"ref=168","doi-asserted-by":"crossref","unstructured":"Park EM, Gelber S, Rosenberg SM, et al. Anxiety and depression in young women with metastatic breast cancer: A cross-sectional study. Psychosomatics. 2018;59(3):251-258","DOI":"10.1016\/j.psym.2018.01.007"},{"key":"ref=169","doi-asserted-by":"crossref","unstructured":"Rodin G. Effective treatment for depression in patients with cancer. Lancet. 2014;384(9948):1076-1078","DOI":"10.1016\/S0140-6736(14)61342-8"},{"key":"ref=170","unstructured":"Li M, Kennedy EB, Byrne N, Gerin-Lajoie C, Green E, Katz MR, et al. The Management of Depression in Patients with Cancer. Vol. 11. Toronto: Cancer Care Ontario; 2015. pp. 19-14"},{"key":"ref=171","unstructured":"\u0141uczak J, Kotli\u0144ska-Lemieszek A. Opieka paliatywna\/hospicyjna\/medycyna paliatywna. Nowiny Lekarskie. 2011;80:3-15"}],"container-title":["Supportive and Palliative Care and Quality of Life in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.intechopen.com\/download\/pdf\/82200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T18:53:41Z","timestamp":1727463221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.intechopen.com\/chapters\/82200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"ISBN":["9781803561851","9781803561868"],"references-count":171,"URL":"https:\/\/doi.org\/10.5772\/intechopen.105220","relation":{},"subject":[],"published":{"date-parts":[[2023,1,11]]}}}